Tomohiro Miyake

1.1k total citations
55 papers, 749 citations indexed

About

Tomohiro Miyake is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Tomohiro Miyake has authored 55 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cancer Research, 26 papers in Oncology and 23 papers in Molecular Biology. Recurrent topics in Tomohiro Miyake's work include Breast Cancer Treatment Studies (14 papers), HER2/EGFR in Cancer Research (13 papers) and Cancer Genomics and Diagnostics (13 papers). Tomohiro Miyake is often cited by papers focused on Breast Cancer Treatment Studies (14 papers), HER2/EGFR in Cancer Research (13 papers) and Cancer Genomics and Diagnostics (13 papers). Tomohiro Miyake collaborates with scholars based in Japan, Germany and United States. Tomohiro Miyake's co-authors include Shinzaburo Noguchi, Kenzo Shimazu, Yasuto Naoi, Seung Jin Kim, Masafumi Shimoda, Naofumi Kagara, Tomonori Tanei, Takahiro Nakayama, Yasuhiro Tamaki and Noriaki Yamamoto and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Tomohiro Miyake

51 papers receiving 743 citations

Peers

Tomohiro Miyake

ONCOL

PFM

PRM

Samira Majjaj Belgium

F. Lerebours France

Fangmeng Fu China

Sonya Parpart-Li United States

V. Feillel France

Gennaro Limite Italy

Eoghan Ruadh Malone Canada

Nick Beije Netherlands

Cynthia Aparecida Bueno de Toledo Osório Brazil

Hong Ling China

Samira Majjaj Belgium

Tomohiro Miyake

449 ×1.1

498 ×1.6

321 ×1.2

ONCOL

103 ×0.7

PFM

145 ×1.3

PRM

Citations per year, relative to Tomohiro Miyake Tomohiro Miyake (= 1×) peers Samira Majjaj

Countries citing papers authored by Tomohiro Miyake

Since Specialization

Citations

This map shows the geographic impact of Tomohiro Miyake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomohiro Miyake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomohiro Miyake more than expected).

Fields of papers citing papers by Tomohiro Miyake

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomohiro Miyake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomohiro Miyake. The network helps show where Tomohiro Miyake may publish in the future.

Co-authorship network of co-authors of Tomohiro Miyake

This figure shows the co-authorship network connecting the top 25 collaborators of Tomohiro Miyake. A scholar is included among the top collaborators of Tomohiro Miyake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomohiro Miyake. Tomohiro Miyake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shimoda, Masafumi, Kaori Abe, Tetsuhiro Yoshinami, et al.. (2025). Isolated splenic metastasis presenting at diagnosis of HER2-positive de novo metastatic breast cancer: a case report. Journal of Surgical Case Reports. 2025(9). rjaf751–rjaf751.

Tanei, Tomonori, Shigeto Seno, Tetsuhiro Yoshinami, et al.. (2025). High HER2 Intratumoral Heterogeneity Is Resistant to Anti-HER2 Neoadjuvant Chemotherapy in Early Stage and Locally Advanced HER2-Positive Breast Cancer. Cancers. 17(13). 2126–2126. 2 indexed citations

Miyake, Tomohiro, et al.. (2024). Early Ambulation Following Lung Resection Surgery: Impact on Short-term Outcomes in Patients with Lung Cancer. PubMed. 27(1). 42–48. 1 indexed citations

Shimoda, Masafumi, Yasufumi Sato, Kaori Abe, et al.. (2024). Prognostic value of serum tartrate‑resistant acid phosphatase‑5b for bone metastasis in patients with resectable breast cancer. Oncology Letters. 27(6). 250–250. 1 indexed citations

Tanei, Tomonori, Shigeto Seno, Kaori Abe, et al.. (2024). High HER2 Intratumoral Heterogeneity Is a Predictive Factor for Poor Prognosis in Early-Stage and Locally Advanced HER2-Positive Breast Cancer. Cancers. 16(5). 1062–1062. 5 indexed citations

Abe, Kaori, Tadashi Watabe, Kazuko Kaneda‐Nakashima, et al.. (2024). Evaluation of Targeted Alpha Therapy Using [211At]FAPI1 in Triple-Negative Breast Cancer Xenograft Models. International Journal of Molecular Sciences. 25(21). 11567–11567. 2 indexed citations

Hashimoto, Yoko, Naofumi Kagara, Kaori Abe, et al.. (2023). Detection of Ultra-Rare ESR1 Mutations in Primary Breast Cancer Using LNA-Clamp ddPCR. Cancers. 15(9). 2632–2632. 4 indexed citations

Kagara, Naofumi, Yasuyo Ohi, Kaori Abe, et al.. (2023). Evaluation of RASSF1A methylation in the lysate of sentinel lymph nodes for detecting breast cancer metastasis: A diagnostic accuracy study. Oncology Letters. 26(5). 475–475. 3 indexed citations

Miyake, Tomohiro & Kenzo Shimazu. (2023). Third-look contrast-enhanced ultrasonography plus needle biopsy for differential diagnosis of magnetic resonance imaging-only detected breast lesions. Journal of Medical Ultrasonics. 51(4). 599–604. 1 indexed citations

10.

Asai, Yuki, et al.. (2022). A Questionnaire Survey on the Current Status of Cooperation between Community Pharmacies and Hospitals in Perioperative Management in Mie Prefecture. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 48(9). 368–378.

11.

Sato, Yasufumi, Masafumi Shimoda, Tomohiro Miyake, et al.. (2021). Enhanced humoral immunity in breast cancer patients with high serum concentration of anti‐HER2 autoantibody. Cancer Medicine. 10(4). 1418–1430. 9 indexed citations

12.

Kim, Seung Jin, Yasuto Naoi, Keiichiro Honma, et al.. (2020). Determining homologous recombination deficiency scores with whole exome sequencing and their association with responses to neoadjuvant chemotherapy in breast cancer. Translational Oncology. 14(2). 100986–100986. 12 indexed citations

13.

Okuno, Jun, Tomohiro Miyake, Tomonori Tanei, et al.. (2020). Development of Prediction Model Including MicroRNA Expression for Sentinel Lymph Node Metastasis in ER-Positive and HER2-Negative Breast Cancer. Annals of Surgical Oncology. 28(1). 310–319. 17 indexed citations

14.

Naoi, Yasuto, Kenzo Shimazu, Masafumi Shimoda, et al.. (2019). Clinicopathological analysis of homologous recombination-deficient breast cancers with special reference to response to neoadjuvant paclitaxel followed by FEC. Breast Cancer Research and Treatment. 174(3). 627–637. 15 indexed citations

15.

Shimazu, Kenzo, Tomohiro Miyake, Jun Okuno, et al.. (2019). One-step Nucleic Acid Amplification Can Identify Sentinel Node-negative Breast Cancer Patients With Excellent Prognosis. Anticancer Research. 39(3). 1447–1454. 12 indexed citations

16.

Miyake, Tomohiro, Kenzo Shimazu, Tomonori Tanei, et al.. (2019). Hookwire-guided Sentinel Lymph Node Biopsy Using Contrast-enhanced Ultrasonography Followed by a One-step Nucleic Acid Amplification (OSNA) Assay for Breast Cancer. Anticancer Research. 39(11). 6183–6192. 7 indexed citations

17.

Shimoda, Masafumi, Tomohiro Miyake, Tomonori Tanei, et al.. (2019). Prognostic value of tumor cell DNA content determined by flow cytometry using formalin-fixed paraffin-embedded breast cancer tissues. Breast Cancer Research and Treatment. 176(1). 75–85. 5 indexed citations

18.

Kagara, Naofumi, Tomohiro Miyake, Tomonori Tanei, et al.. (2017). Detection of ESR1 mutations in plasma and tumors from metastatic breast cancer patients using next-generation sequencing. Breast Cancer Research and Treatment. 163(2). 231–240. 28 indexed citations

19.

Miyake, Tomohiro, Takashi Ito, Ayako Yanai, et al.. (2013). C4.4A highly expressed in HER2-positive human breast cancers may indicate a good prognosis. Breast Cancer. 22(4). 366–373. 6 indexed citations

20.

Miyake, Tomohiro, Takahiro Nakayama, Yasuto Naoi, et al.. (2012). GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER‐negative breast cancer. Cancer Science. 103(5). 913–920. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact